Literature DB >> 12620966

The dystrophin associated protein complex in zebrafish.

J R Guyon1, A N Mosley, Y Zhou, K F O'Brien, X Sheng, K Chiang, A J Davidson, J M Volinski, L I Zon, L M Kunkel.   

Abstract

Many cases of muscular dystrophy in humans are caused by mutations in members of the dystrophin associated protein complex (DAPC). Zebrafish are small vertebrates whose bodies are composed predominantly of skeletal muscle, making them attractive models for studying mammalian muscle disorders. Potential orthologs to most of the human DAPC proteins have been found in zebrafish by database screening. Expression of the sarcoglycans, dystroglycan and dystrophin has been confirmed by western blotting. Immunohistochemical and biochemical techniques localize these proteins to the muscle cell membrane in adult zebrafish. Morpholino (MO) experiments designed to inhibit the translation of dystrophin mRNA produce juvenile zebrafish that are less active than zebrafish injected with control morpholinos. Western blot analysis of the dystrophin morpholino-injected zebrafish shows concurrent reduction of dystrophin and the sarcoglycans, suggesting that these proteins, like those in mammals, are part of a complex whose integrity is dependent on dystrophin expression. These results indicate that the zebrafish is an excellent animal model in which to approach the study of dystrophin and its associated proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620966

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

Review 1.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

2.  The zebrafish runzel muscular dystrophy is linked to the titin gene.

Authors:  Leta S Steffen; Jeffrey R Guyon; Emily D Vogel; Melanie H Howell; Yi Zhou; Gerhard J Weber; Leonard I Zon; Louis M Kunkel
Journal:  Dev Biol       Date:  2007-06-23       Impact factor: 3.582

3.  The development of the myotendinous junction. A review.

Authors:  Benjamin Charvet; Florence Ruggiero; Dominique Le Guellec
Journal:  Muscles Ligaments Tendons J       Date:  2012-09-10

4.  Drug screening in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Genri Kawahara; Jeremy A Karpf; Jennifer A Myers; Matthew S Alexander; Jeffrey R Guyon; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

Review 5.  Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies.

Authors:  Elizabeth M Gibbs; Eric J Horstick; James J Dowling
Journal:  FEBS J       Date:  2013-07-25       Impact factor: 5.542

Review 6.  Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Authors:  Louis M Kunkel; Estanislao Bachrach; Richard R Bennett; Jeffrey Guyon; Leta Steffen
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

Review 7.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

8.  Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos.

Authors:  Christelle Etard; Urmas Roostalu; Uwe Strähle
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

9.  Zebrafish models for human FKRP muscular dystrophies.

Authors:  Genri Kawahara; Jeffrey R Guyon; Yukio Nakamura; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2009-12-01       Impact factor: 6.150

Review 10.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.